In Vivo Pharmacodynamic Characterization of T-705 in an Experimental Influenza Infection Model in Mice

被引：0
|
作者：
Takahashi, K. [1 ]
Kadota, T. [1 ]
Tanaka, T. [1 ]
Komeno, T. [1 ]
Hayakawa, H. [1 ]
Mitsuyama, J. [1 ]
Furuta, Y. [2 ]
Shiraki, K. [3 ]
机构：
[1] Toyama Chem Co LTD, Res Labs, Toyama, Japan
[2] Toyama Chem Co LTD, Business Dev Dept, Tokyo, Japan
[3] Toyama Univ, Dept Virol, Toyama 930, Japan
来源：
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES | 2008年 / 12卷
关键词：
D O I：
10.1016/j.ijid.2008.05.425
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：E170 / E171
页数：2
相关论文
共 50 条
  • [21] Distinct Effects of T-705 (Favipiravir) and Ribavirin on Influenza Virus Replication and Viral RNA Synthesis
    Vanderlinden, Evelien
    Vrancken, Bram
    Van Houdt, Jeroen
    Rajwanshi, Vivek K.
    Gillemot, Sarah
    Andrei, Graciela
    Lemey, Philippe
    Naesens, Lieve
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2016, 60 (11) : 6679 - 6691
  • [22] T-705, A Novel Anti-Influenza Virus Compound - the Safety, Tolerability and Pharmacokinetics in Human
    Kobayashi, O.
    Noto, M.
    Sakurai, T.
    Iwamoto, A.
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2008, 12 : E299 - E299
  • [23] Anti-influenza Virus Activity of Methylthio-Formycin Distinct From That of T-705
    Takizawa, Naoki
    Takada, Hisashi
    Umekita, Maya
    Igarashi, Masayuki
    Takahashi, Yoshiaki
    FRONTIERS IN MICROBIOLOGY, 2022, 13
  • [24] Activity of T-705 in a Hamster Model of Yellow Fever Virus Infection in Comparison with That of a Chemically Related Compound, T-1106
    Julander, Justin G.
    Shafer, Kristiina
    Smee, Donald F.
    Morrey, John D.
    Furuta, Yousuke
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2009, 53 (01) : 202 - 209
  • [25] Evaluation of the effects of favipiravir (T-705) on the lung tissue of healty rats: An experimental study
    Ulger, Menekse
    Ulger, Birkan
    Turan, Isil Tugce
    Temel, Sahin
    Yay, Arzu
    Yalcin, Betul
    Yakan, Birkan
    FOOD AND CHEMICAL TOXICOLOGY, 2025, 196
  • [26] Favipiravir (T-705) Inhibits Junin Virus Infection and Reduces Mortality in a Guinea Pig Model of Argentine Hemorrhagic Fever
    Gowen, Brian B.
    Juelich, Terry L.
    Sefing, Eric J.
    Brasel, Trevor
    Smith, Jennifer K.
    Zhang, Lihong
    Tigabu, Bersabeh
    Hill, Terence E.
    Yun, Tatyana
    Pietzsch, Colette
    Furuta, Yousuke
    Freiberg, Alexander N.
    PLOS NEGLECTED TROPICAL DISEASES, 2013, 7 (12):
  • [27] Assessment of toxicological effects of favipiravir (T-705) on the lung tissue of rats: An experimental study
    Erbas, Elif
    Celep, Nevra Aydemir
    Tekiner, Deniz
    Genc, Aydin
    Gedikli, Semin
    JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY, 2024, 38 (01)
  • [28] Favipiravir (T-705) Protects IFNAR-/- Mice against Lethal Zika Virus Infection in a Sex-Dependent Manner
    Matz, Keesha
    Emanuel, Jackson
    Callison, Julie
    Gardner, Don
    Rosenke, Rebecca
    Mercado-Hernandez, Reinaldo
    Williamson, Brandi N.
    Feldmann, Heinz
    Marzi, Andrea
    MICROORGANISMS, 2021, 9 (06)
  • [29] Intracellular conversion and in vivo dose response of favipiravir (T-705) in rodents infected with Ebola virus
    Bixler, Sandra L.
    Bocan, Thomas M.
    Wells, Jay
    Wetzel, Kelly S.
    Van Tongeren, Sean A.
    Garza, Nicole L.
    Donnelly, Ginger
    Cazares, Lisa H.
    Soloveva, Veronica
    Welch, Lisa
    Epstein, Carol
    Liang, Li-Fang
    Giesing, Dennis
    Lenk, Robert
    Bavari, Sina
    Warren, Travis K.
    ANTIVIRAL RESEARCH, 2018, 151 : 50 - 54
  • [30] Postexposure Protective Efficacy of T-705 (Favipiravir) Against Sudan Virus Infection in Guinea Pigs
    Rahim, Md N.
    Zhang, Zirui
    He, Shihua
    Zhu, Wenjun
    Banadyga, Logan
    Safronetz, David
    Qiu, Xiangguo
    JOURNAL OF INFECTIOUS DISEASES, 2018, 218 : S649 - S657
12345